FILED

Department of Business and Professvonal Regufatlon
STATE OF FLORIDA AGENCYCHRK
DEPARTMENT OF BUSINESS AND
PROFESSIONAL REGULATION
BOARD OF MEDICINE

DEPARTMENT OF BUSINESS AND CLERK 5.04% !' “WM

PROFESSIONAL REGULATION, DATEW

Petitioner,
v. DBPR CASE NUMBERS: 90-03964
91-09066
LICENSE NUMBER: ME 0048344
FREELAND L. WILLIAMS, II, M.D.,

Respondent.
/

FINAL ORDER

 

THIS MATTER came before the Board of Medicine (Board) pursuant
to Section 120.57(3), Florida Statutes, on December 3, 1993, in

Boca Raton, Florida, for consideration of a Consent Agreement

the above~styled case. Upon consideration of the Consent
Agreement, the documents submitted in support thereof, the
arguments of the parties, and being otherwise advised in the
premises, the Board rejected the Consent Agreement proposed and
offered an amendment at the hearing, which amendment was accepted
without objection by the parties.

IT IS HEREBY ORDERED AND ADJUDGED that the Consent Agreement
as submitted be and is hereby approved and adopted in toto and
incorporated by reference herein with the following amendments:

1. Paragraph 3.B.iv of the stipulated Disposition is amended
to reflect the additional restriction that the Respondent shall not
prescribe, dispense, mix, administer or order Schedule II1 and

Schedule III controlled substance medications, however, he may

order such medications for administration to patients in a hospital
accredited by the Joint Commission on Accreditation of Healthcare
Organizations (JCAHO) and not for outpatient use.

2. The Respondent shall review and become familiar with the
provision of Drug Abuse Prevention and Control, Chapter 893,

Florida Statutes.

This Final Order takes effect upon filing with the Clerk of

the Department.

DONE AND ORDERED this 23 day MW , 1993.
_h a

BOARD OF MEDICINE

    

EDWARD A. DAUER, M.D.
CHAIRMAN

CERTIFICATE OF SERVI CE
I HEREBY CERTIFY that a true and correct copy of the foregoing
has been provided by certified U.S. Mail to Freeland L. Williams,
II, M.D., 919 14th Lane, Vero Beach, Florida 32960—4735, Steven R.
Ballinger, Esquire, Law Offices of Morris & Green, 2500 Hollywood
Boulevard, Suite 212, Hollywood, Florida 33020 and by interoffice
delivery to Larry G. McPherson, Jr., Chief Medical Attorney,

Department of Business and Professional Regulation, Northwood

8. Respondent and the Department fully understand that this joint Agreement and subsequent
Final Order incorporating same will in no way preclude additional proceedings by the Board and/or
the Department against the Respondent for acts or omissions not speciﬁcally set forth in the
Administrative Complaint attached as Exhibit "A” herein.

9. Upon the Board’s adoption of this Agreement, Respondent expressly waives all further
procedural steps, and expressly waives all rights to seek judicial review of or to otherwise challenge
or contest the validity of the Agreement and the Final Order of the Board incorporating said
Agreement.

10. Upon the Board‘s adoption of this Agreement, the parties hereby agree that each party will
bear his own attomey’s fees and costs resulting from prosecution or defense of this matter.
Respondent waives the right to seek any attorney's fees or costs from the Department in connection
with this matter.

ll. This Agreement is executed by the Respondent for the purpose of avoiding. further
administrative action with respect‘to this cause. in this regard, Respondent authorizes the Board to
review and examine all investigative ﬁle materials concerning Respondent prior to or in conjunction
with consideration of the Agreement. Furthermore, should this joint Agreement not be accepted by

the Board, it is agreed that presentation to and consideration of this Agreement and other documents

OQGUH

and mum by the Board shall not unfairly or illegally prqiudioe the Board or any of its member: ﬁogn
funher participation, considmtion or molatlon of these pmoeedhazs.
SIGNED mi: 51%., of 0‘3" . 1993.

MW

Freeland L. Williams. 11, MD.
Befoue me pmomllz append ﬁg; (Mi; 2434.3,“ :1 140, whose identity is known to me

by 66.: amal (type of identiﬁcation) and who. under oath.
acknowledges that his signature appears above.

Sworn to and subscribed before me thisJLZ day of M, 1993.

 

    

 

 

[:‘f’V Chief At'tomcy
Medical Secﬁon

000012

PROVISIONS REGARDING MONITORING/SUPERVISING PHYSICIANS

Provisions governing physicians ordered to work under supervision of monitoring or

supervising physician.
1. W!

A. INDIREQI SUPERVISIQN is supervision by a monitoring physician (monitor)

whose responsibilities are set by the Board. Indirect supervision does not require that the monitor

practice on the same premises as the Respondent, however, the monitor shall practice within a
reasonable geographic proximity to Respondent, which shall be within 20 miles unless otherwise

provided by the Board and shall be readily available for consultation. The monitor shall be Board-

certiﬁed in the Respondent's specialty area unless otherwise provided by the Board.
B. DIREQIZ SUEEBVISIQN is supervision by a supervising physician (supervisor)
whose responsibilities are set by the Board. Direct supervision requires that the supervisor and

Respondent work in the same ofﬁce. The supervising physician shall be board—certiﬁed in the

Respondent’s specialty area unless otherwise provided by the Board.

C. EBQBgTIQﬂ QEQMMI'ITEE or "committee" are members of the Board of Medicine

designated by the Chairman of the Board to serve as the Probation Committee.

II. ETANDARD IERMS.

A. RE IRED S PERVI [ON

1. The Respondent shall not practice medicine without an approved

monitor/supervisor, as speciﬁed by the Consent Agreement, unless othefwise ordered by the Board.

2. The monitor/supervisor must be a licensee under Chapter 458, Florida

Statutes, in good standing and without restriction or limitation on his license. In addition, the Board

10

000MB

ow Canmmittee may reject any proposed monitor/supervisor on the basxs that he has previously been
51151ch to any disciplinary action against his medical license in this or any other jurisdiction, is
cutrmﬂy under investigation, or is the subject of a pending disciplinary action. The
mﬁxmr/supervisor must be actively engaged in the same or similar specialty area unless otherwise
Inmdded by the Board or Committee. The Board or Committee may also reject any proposed

mmmmorlwpervisor for good cause shown.
B. H M F R PPR VAL M PERVI :
l. TEMPQRARY APPRQVAL. The Board confers authority on the Chairman
05' time Board‘s Probation Committee to temporarily approve Respondent's monitor/supervisor. To
obtamn this temporary approval, Respondent shall submit to the Chairman of the Probation Committee

the rmame and curriculum vitae of the proposed monitor/supervisor at the time this agreement is
omnidered by the Board. Once a Final Order adopting this Agreement is ﬁled, Respondent shall
n1 pntactice medicine without an approved monitor/supervisor. Temporary approval shall only

main in effect until the next meeting of the Probation Committee.

2. FQRMAL APPROVAL.

21. Respondent shall have the monitor/supervisor with him at his ﬁrst
pinbaatjon appearance before the Probation Committee. Prior to consideration of the
mmor/supervisor by the Committee, the Respondent shall provide to the monitor/supervisor a copy
of the: Administrative Complaint and Final Order in this case. Respondent shall submit a current
ctmcruium vitae and a description of current practice from the proposed monitor/supervisor to the

Emmi ofﬁce no later than fourteen days before the Respondent‘s ﬁrst scheduled probation appearance.

ll

0008M

b. Respondent‘s monitor/supervisor shall also appear before the
Probation Committee at such other times as directed by the Committee. It shall be Respondent’s
responsibility to ensure that the appearance of his monitor/supervisor as directed. Failure of the
monitor/supervisor to appear as directed shall constitute a violation of the terms of this Stipulation and
shall subject the Respondent to disciplinary action.

3. QHANgiE IN MQNITQMSQPERVISQR. In the event that Respondent's
monitor/supervisor is unable or unwilling to fulﬁll his responsibilities as a monitor/supervisor as
described above, then the Respondent shall immediately advise the Board of this fact. Respondent
shall immediately submit to the Chairman of the Board’s Probation Committee the name of a
temporary monitor/supervisor for consideration. Respondent shall not practice pending approval of
this temporary monitor/supervisor by the Chairman of the Probation Committee. Furthermore,

Respondent shall make arrangements with his tempo‘mry monitor/supervisor to appear before the
Probation Committee at its next regularly scheduled meeting for consideration of the
monitor/supervisor by the Committee. Respondent shall only practice under the auspices of the
temporary monitor/supervisor (approved by the Chairman) until the next regularly scheduled meeting
of the Probation Committee whereat the issue of the Committee‘s approval of the Respondent's new

monitor/supervisor shall be addressed.

C. QQNTINUITY OF PRACTICE
1. TQLLINQ PRQVISIQNS. In the event the Respondent leaves the State of

Florida for a period of thirty days or more or otherwise does not engage in the active practice of

medicine in the State of Florida, then certain provisions of Respondent‘s probation (and only those

12

provisions of the probation) shall be tolled as enumerated below and shall remain in a tolled status
until Respondent returns to active practice in the State of Florida.

a. The time period of probation shall be tolled.

b. The provisions regarding supervision whether direct or indirect by
another physician, and required reports from the monitor/supervisor shall be tolled.

c. The provisions regarding preparation of investigative reports detailing
compliance with this Stipulation shall be tolled.

2. ADDRQSE. Respondent must keep current residence and business
addresses on file with the Board. Respondent shall notify the Board within ten (10) days of any
changes of said addresses. Furthermore, Respondent shall notify the Board within ten (10) days in
the event that Respondent leaves the active practice of medicine in Florida.

3. AQTIVE PRACTICE. In the event that Respondent leaves the active practice
of medicine for a period of one year or more, the Probation Committee may require Respondent to
appear before the Probation Committee and demonstrate his ability to practice medicine with skill and
safety to patients pn'or to resuming the practice of medicine in this State.

D. 998—11 Respondent shall pay all costs necessary to comply with the terms of this
Consent Agreement. Such costs include, but are not limited to, the costs of preparation of
Investigative Reports detailing compliance with the terms of the Consent Agreement, and the Board‘s
administrative costs directly associated with Respondent’s probation.

E. BOARD ADDRESS. Unless otherwise directed by the Board ofﬁce, all reports,
correspondence and inquiries shall be sent to: Board of Medicine, 1940 North Monroe Street,

Tallahassee, Florida 32399—0750, Attn: Final Order Compliance Ofﬁcer,

13

STATE OF FLORIDA
DEPARTMENT OF PROFESSIONAL REGULATION
BOARD OF MEDICINE

DEPARTMENT OF PROFESSIONAL
REGULATION,

PETITIONER,
vs. CASE NO. 90-03964
FREELAND WILLIAMS, M.D.

RESPONDENT.
__________________________/
ADMINISTRATIVE COMPLAINT

COMES NOW the Petitioner, Department of Professional
Regulation, hereinafter referred to as "Petitioner," and files this
Administrative Complaint before the Board of Medicine against
FREELAND WILLIAMS, M.D., hereinafter referred to as "Respondent,"
and alleges:

1. Petitioner is the state agency charged with regulating
the practice of medicine pursuant to Section 20.30, Florida
Statutes; Chapter 455, Florida Statutes; and Chapter 458, Florida
statutes.

2. Respondent is and has been at all times material hereto
a licensed physician in the State of Florida, having been issued
license number ME 0048344. Respondent's last known address is 919
14th Lane, Vero Beach, Florida 32960-4735.

FACTS PERTAINING TO PATIENT £1

3. Percocet is a legend drug as defined by Section
465.003(7), Florida Statutes, and contains oxycodone hydrochloride
5 milligrams (mg.), a controlled substance listed in Schedule II

1

0088i?

of Chapter 893, Florida statutes, and acetaminophen 325 mg.

4. Percodan is a legend drug as defined by Section
465.003(7), Florida Statutes, and contains oxycodone hydrochloride
4.5 mg. and oxycodone terephthalate .38 mg., controlled substances
listed in Schedule II of Chapter 893, Florida Statutes, and aspirin
325 mg.

5. Roxicet is a legend drug as defined by Section
465.003(7), Florida statutes, and contains oxycodone hydrochloride
5 mg., a controlled substance listed in Schedule II of Chapter 893,
Florida statutes, and acetaminophen 325 mg.

6. Tylox is a legend drug as defined by Section 465.003(7),
Florida Statutes, and contains oxycodone hydrochloride 5 mg., a
controlled substance listed in Schedule II of Chapter 893, Florida
statutes, and acetaminophen 500 mg.

7. oxycodone hydrochloride, with either acetaminophen or
aspirin, is indicated for the relief of moderate to moderately
severe pain. Oxycodone can produce drug dependency of the morphine
type and has the potential for being abused.

8. The usual adult dose of Percocet, Percodan, Roxicet,
Tylox, and generic oxycodone hydrochloride is one (1) tablet every
six (6) hours as needed for pain.

9. From on or about November 11, 1988, to on or about
December 4, 1990, Respondent provided medical care and treatment
to Patient #1.

10. On or about November 30, 1988, Patient presented to

Respondent subsequent to suffering severe constant pain, from the

OODBIB

base of the right side of the neck radiating into the right hand,
beginning the previous day. Respondent prescribed Percodan #30.

11. From on or about November 30, 1988, to on or about
December 4, 1990, Respondent continuously prescribed either
Percodan or Percocet, totalling about 13,660 tablets (an average
of almost 19 tablets per day), to Patient #1.

12. From on or about January 14, 1989, to on or about January
16, 1990, Respondent prescribed generic oxycodone hydrochloride,
including Roxicet, totalling about 529 tablets (an average of
almost 1.5 per day), to Patient #1.

13. From on or about March 11, 1989, to on or about August
31, 1989, Respondent prescribed Tylox, totalling about 350 tablets
(an average of just over 2 per day), to Patient #1.

14. From on or about August 11, 1990, to on or about August
31, 1990, Respondent prescribed Tylox, totalling about 105 tablets
(an average of about 5.25 per day), to Patient #1.

15. From on or about November 30, 1988, to on or about
December 4, 1990, Respondent prescribed oxycodone to Patient #1,
totalling about 14,650 tablets, for an average of just over twenty
(20) tablets per day.

16. On or about March 8, 1989, Respondent switched Patient
#1 from Percodan to Percocet, as the Percodan was upsetting Patient
fl’s stomach.

17. On or about March 22, 1989, Respondent switched Patient
#1 from Percocet to Demerol, as the Percocet was not working.

18. On or about March 24, 1989, Respondent switched Patient

0000i9

#1 from Demerol back to Percocet, as the Demerol was causing nausea
and a dazed feeling.

19. On or about April 18, 1989, Respondent referred Patient
#1 for a neurosurgical consultation.

20. On or about May 3, 1989, Respondent prescribed Percocet
#40 to Patient #1, and noted in his records that Patient #1 was
requiring high doses of Percocet to control pain.

21. on or about May 4, 1989, Respondent switched Patient #1
from Percocet to Dilaudid, and noted that Patient #1 was taking too
many Percocet.

22. On or about May 5, 1989, Respondent switched Patient #1
from Dilaudid back to Percocet, as the Dilaudid was not working.

23. On or about July 7, 1989, Respondent switched Patient #1
from Percocet to Tylox, without reflecting in the records any
reason for the change.

24. On or about July 12, 1989, Respondent switched Patient
#1 from Tylox back to Percocet.

25. On or about August 3, 1989, Patient #1 received a letter
from the neurosurgeon which indicated there was no objective
evidence to support Patient #l’s complaint of chronic pain. This
neurosurgeon further referred Patient #1 to another physician for
chronic pain management.

26. On or about November 2, 1989, Respondent prescribed
Percocet #100 to Patient #1, and noted he discussed a probable
addiction with Patient #1.

27. On or about November 13, 1989, Respondent prescribed

000820

Centre, 1940 North Monroe street, Tallahassee, Florida 32399—0792,

at or before 5:00 P.M., this 2f? day of I éce cf
\
1993.

 

MARM M. HARRIS, Ph.D.

Executive Director

Percocet #100 to Patient #1, and discussed reducing Patient #1’s
Percocet to 25 per day during the current week and to 20 per day
the following week.

28. On or about November 15, 1989, and on or about November
17, 1989, Respondent prescribed Percocet #75 (for a total of 150
tablets) to Patient #1.

29. On or about November 19, 1989, Respondent prescribed
Percocet #50 to Patient #1.

30. On or about November 20, 1989, Respondent prescribed
Percooet #75 to Patient #1.

31. On or about November 21, 1989, Respondent prescribed
Percocet #100 to Patient #1.

32. On or about November 26, 1989, Respondent denied Percocet
to Patient #1.

33. On or about November 27, 1989, Respondent prescribed
Percocet #100 to Patient #1, and noted that Patient #1 agreed to
gradually reduce the Percocet to 25 per day.

34. On or about November 29, 1989, Respondent prescribed
Percocet #50 to Patient #1, and recorded a note to gradually
decrease the amount.

35. On or about November 30, 1989, Respondent prescribed
Percooet #100 to Patient #1.

36. On or about January 30, 1990, Respondent prescribed
Percocet #60 to Patient #1, and noted a discussion with Patient #1
of taking too many Percocet.

37. On or about March 23, 1990, Respondent recorded that

088825

Patient #1 will stop taking Percocet, and that Patient #1 should
expect withdrawal symptoms.

38. From on or about March 27, 1990, to on or about April 24,
1990, Respondent prescribed about 740 Percocet tablets to Patient
#1.

39. On or about April 30, 1990, Respondent recorded that
Patient #1 was "stopping all narcotics that weekend," and then
prescribed Percocet #80 to Patient #1.

40. On or about May 4, 1990, Respondent prescribed Percocet
#80 to Patient #1, and noted that he would give no further
prescriptions to Patient #1.

41. On or about May 7, 1990, and May 8, 1990, Respondent
prescribed 120 Percocet tablets to Patient #1.

42. On or about May 12, 1990, Respondent discussed a therapy
to reduce Patient #1’5 medication by giving the medicatioh to
Patient #l's wife to ration out to Patient #1.

43. From on or about May 14, 1990, to on or about May 28,
1990, Patient #1 was in a detoxification center.

44. On or about May 30, 1990, Respondent recorded that
Patient #1 was "on no Percocet—doing fairly well."

45. on or about July 16, 1990, Respondent prescribed Tylox
#12 to Patient #1, and noted that Patient #1 exacerbated his
chronic neck and shoulder pain.

46. On or about August 28, 1990, Patient #1 admitted to being

addicted to Tylox and requested to be taken off the medication.

080822

47. From on or about August 31, 1990, to on or about
September 20, 1990, Respondent prescribed about 116 Tylox tablets
to Patient #1, for an average of almost six (6) per day.

48. On or about September 24, 1990, Patient #1 admitted to
using extra Tylox. Respondent prescribe Percocet #40 and
instructed Patient to bring the medication to Respondent so
Respondent could dispense the medication to Patient #1.

49. On or about November 17, 1990, Respondent prescribed
Percocet #40 to Patient #1, and recorded that Patient #1 was to
receive no more Percocet.

50. From on or about November 23, 1990, to on or about
December 4, 1990, Respondent prescribed about 197 Percocet tablets
to Patient #1.

51. From on or about January 10, 1989, to on or about June
1, 1989, Patient #1 received about 435 Percodan, Percocet, Tylox,
or generic oxycodone tablets from physicians other than Respondent.

COUNT ONE

52. Petitioner realleges and incorporates paragraphs one (1)
through fifty-one (51), as if fully set forth herein this Count
One. I

53. Respondent prescribed, dispensed, administered, mixed,
or otherwise prepared a legend drug, including any controlled
substance, other than in the course of his professional practice,
in that Respondent prescribed excessive quantities of controlled
substances, including Percocet, Percodan, Roxicet, and Tylox, to

Patient #1 over an extended period of time, continued to prescribe

088323

controlled substances to Patient #1 after recording that Patient
#1 would not receive any more prescriptions for, but not limited
to, Percocet, and Respondent continued to prescribe controlled
substances to Patient #1 after Patient #1 attempted detoxification
programs.

54. Based on the foregoing, Respondent violated Section
458.331(1)(q), Florida Statutes, by prescribing, dispensing,
administering, mixing, or otherwise preparing a legend drug,
including any controlled substance, other than in the course of the
physician's professional practice.

COUNT TWO

55. Petitioner realleges and incorporates paragraphs one (1)
through fifty-one (51), and fifty—three (53), as if fully set forth
herein this Count Two.

56. Respondent failed to practice medicine with that level
of care, skill, and treatment which is recognized by a reasonably
prudent similar physician as being acceptable under similar
conditions and circumstances, in that Respondent inappropriately
treated Patient #1 in an inappropriate manner by allowing Patient
#1’5 wife to dispense the medication, and continued to treat
Patient #1 with excessive quantities of controlled substances,
attempted to detoxify Patient #1 with controlled substances after
Patient #1 entered detoxification programs and after recording that
Patient #1 would not be given further prescriptions for, but not

limited to, Percocet.

57. Based on the foregoing, Respondent violated Section

GBGQZh

458.331(1)(t), Florida Statutes, by gross or repeated malpractice
or the failure to practice medicine with that level of care, skill,
and treatment which is recognized by a reasonably prudent similar
physician as being acceptable under similar conditions and
circumstances.

COUNT THREE

58. Petitioner realleges and incorporates paragraphs one (1)
through fifty-one (51), fifty-three (53), and fifty-six (56), as
if fully set forth herein this Count Three.

59. Respondent failed to keep written medical records
justifying the course of treatment of Patient #1, in that
Respondent's records fail to justify the excessive prescribing of
controlled substances to Patient #1 when Patient #1 failed to
demonstrate any objective evidence to support complaints of chronic
pain, and that the records fail to justify the continued
prescribing of controlled substances to Patient #1 after Respondent
noted in the records that Patient #1 would not receive any more
prescriptions for controlled substances from Respondent.

60. Based on the foregoing, Respondent violated Section
458.331(1)(m), Florida Statutes, by failing to keep written medical
records justifying the course of treatment of the patient,
including, but not limited to, patient histories; examination
results; test results; records of drugs prescribed, dispensed, or
administered; and reports of consultations and hospitalizations.

FACTS EERTAINING T0 EATIENT £2

61. Darvocet N-1oo is a legend drug as defined by Section

{388825

465.003(7), Florida Statutes, contains propoxyphene napsylate 100
milligrams (mg.), a controlled substance listed in Schedule IV of
Chapter 893, Florida Statutes, and acetaminophen 650 mg., and is
indicated for the relief of mild to moderate pain, where pain is
present with or without fever.

62. Propoxyphene, when taken in higher than recommended doses
over long periods of time, can produce drug dependence
characterized by psychic dependence and, less frequently, physical
dependence and tolerance. The maximum recommended dose of
propoxyphene is 600 mg. per day.

63. Vicodin is a legend drug as defined by Section
465.003(7), Florida Statutes, contains hydrocodone bitartrate, a
controlled substance listed in Schedule III of Chapter 893, Florida
Statutes, and acetaminophen, and is indicated for the relief of
moderate to moderately severe pain.

64. Lorcet HD and Lorcet Plus are legend drugs as defined by
Section 455.003(7), Florida Statutes, contain hydrocodone
bitartrate, a controlled substance listed in Schedule III of
Chapter 893, Florida Statutes, and acetaminophen, and are indicated
for the relief of moderate to moderately severe pain.

65. The usual dosage of hydrocodone bitartrate with
acetaminophen is one (1) tablet every six (6) hours and the maximum
dosage is eight (8) tablets in a tWenty—four (24) hour period.
Psychic dependence, physical dependence, and tolerance may develop
upon repeated administration of hydrocodone bitartrate.

66. From on or about October 4, 1988, to on or about December

10

008025

10, 1990, Respondent provided medical care and treatment to Patient
#2.

67. On or about October 4, 1988, Patient #2 presented to
Respondent complaining of having headaches three (3) times per
week, each lasting about ten (10) hours, and pain in the upper
shoulders. Respondent prescribed Darvocet N-1oo #30.

68. From on or about October 4, 1988, to on or about April
9, 1990, Respondent continuously prescribed Darvocet N—1oo,
totalling about 2,500 tablets, to Patient #2.

69. On or about January 13, 1989, Respondent recorded that
he spoke with Patient #2 about Patient #2’5 excessive use of
medication, including, but not limited to, Darvocet N—1oo.

70. From on or about April 14, 1990, to on or about December
4, 1990, Respondent continuously prescribed hydrocodone bitartrate,
either in the form of Lorcet or Vicodin, totalling about 600
tablets, to Patient #2.

71. Respondent's medical records for Patient #2 fail to
reflect any attempts to treat Patient #2'5 pain with alternate
modalities, and fail to reflect any appropriate consultations for
Patient #2'5 pain.

COUNT FOUR

72. Petitioner realleges and incorporates paragraphs one (1),
two (2), and sixty-one (61) through seventy-one (71), as if fully
set forth herein this Count Four.

73. Respondent prescribed, dispensed, administered, mixed,

or otherwise prepared a legend drug, including any controlled

11

008827

substance, other than in the course of his professional practice,
in that Respondent inappropriately and excessively prescribed
controlled substances, including Darvocet N—1oo, Vicodin, and
Lorcet, over extended periods of time to Patient #2.

74. Based on the foregoing, Respondent violated Section
458.331(1)(q), Florida Statutes, by prescribing, dispensing,
administering, mixing, or otherwise preparing a legend drug,
including any controlled substance, other than in the course of the
physician's professional practice.

COUNT FIVE

75. Petitioner realleges and incorporates paragraphs one (1),
two (2), sixty-one (61) through seventy-one (71), and seventy—
three (73), as if fully set forth herein this Count Five.

76. Respondent failed to practice medicine with that level
of care, skill, and treatment which is recognized by a reasonably
prudent similar physician as being acceptable under similar
conditions and circumstances, in that Respondent inappropriately
treated Patient #2 with excessive quantities of controlled
substances over extended periods of time, continued to prescribe
controlled substances to Patient #2 after discussing excessive use
of said substances with Patient #2, and failed to attempt
alternative treatment modalities to manage Patient #Z’S pain.

77. Based on the foregoing, Respondent violated Section
458.331(1)(t), Florida Statutes, by gross or repeated malpractice
or the failure to practice medicine with that level of care, skill,

and treatment which is recognized by a reasonably prudent similar

12

083028

physician as being acceptable under similar conditions and
circumstances.
COUNT SIX

78. Petitioner realleges and incorporates paragraphs one (1),
two (2), sixty—one (61) through seventy-one (71), seventy—three
(73), and seventy-six (76), as if fully set forth herein this Count
Six.

79. Respondent failed to keep written medical records
justifying the course of treatment of Patient #2, in that
Respondent’s records fail to justify the excessive prescribing of
controlled substances to Patient #2, and fail to justify the
continued prescribing of controlled substances to Patient #2 after
discussing Patient #2’5 excessive use of said substances with
Patient #2.

80. Based on the foregoing, Respondent violated Section
458.331(1)(m), Florida Statutes, by failing to keep written medical
records justifying the course of treatment of the patient,
including, but not limited to, patient histories; examination
results; test results; records of drugs prescribed, dispensed, or
administered; and reports of consultations and hospitalizations.

FACTS PERTAINING TO PATIENT £3

81. The repeated administration of hydrocodone bitartrate may
result in psychic dependence, physical dependence and tolerance.

82. From on or about October 18, 1989, to on or about
December 6, 1990, Respondent provided medical care and treatment

to Patient #2 for conditions including, but not limited to,

13

900829

juvenile onset diabetes mellitus and recurring headaches.

83. On or about November 11, 1989, Respondent prescribed
Vioodin to Patient #3, but failed to record the prescription in
Patient #3's medical records.

84. On or about January 16, 1990, Patient #3 presented to
Respondent complaining of a throbbing frontal headache with nausea
and vomiting. Respondent prescribed Fiorinal #30 to Patient #3.

85. Fiorinal is a legend drug as defined by Section
465.003(7), Florida statutes, contains butalbital, a controlled
substance listed in Schedule III of Chapter 893, Florida Statutes,
and is indicated for the relief of the symptom complex of tension
(or muscle contraction) headache.

86. On or about January 17, 1990, Respondent prescribed
Darvocet N—loo #10 to Patient #3, as the Fiorinal was not helping.

87. On or about January 19, 1990, Patient #3 presented to
Respondent complaining of still having a headache, and that the
Darvocet was not helping. Respondent prescribed Vicodin #10 to
Patient #3.

88. From on or about January 19, 1990, to on or about May 16,
1990, Respondent prescribed Vicodin, totalling about 370 tablets,
on approximately a weekly basis to Patient #3.

89. On or about May 19, 1990, Patient #3 requested a refill
of the Vicodin, but Respondent denied the request.

90. On or about May 24, 1990, Respondent discussed Patient
#3’s medication use and potential problem and addiction with

Patient #3.

14

088038

STATE OF FLORIDA
DEPARTMENT OF BUSINESS AND PROFESSIONAL REGULATION

DEPARTMENT OF BUSINESS AND
PROFESSIONAL REGULATION,

Petitioner,

v. DOAH CASE NO. 92-0506
DBPR CASE NO. 90-03964

FREELAND L. WILLIAMS, II, M.D.,

Respondent.
/

£1 QNSENT AﬁREEMENT

Freeland L. Williams, II, M.D., referred to as the "Respondent," and the Department of

Business and Professional Regulation, referred to as “Department, " stipulate and agree to the following

Agreement and to the entry of a Final Order of the Board of Medicine, referred to as “Board,"

incorporating the Stipulated Facts and Stipulated Disposition in this matter.

STIPLJLATED FACTS

1. At all times material hereto, Respondent was a licensed physician in the State of Florida

having been issued license number ME 0048344.
2. Respondent was charged by an Administrative Complaint ﬁled by the Department and
properly served upon Respondent with violations of Chapter 458, Florida Statutes, and the rules

enacted pursuant thereto. A true and correct copy of the Administrative Complaint is attached hereto

as Exhibit A.

00000

‘r.

91. From on or about May 24, 1990, to on or about November
16, 1990, Respondent prescribed Vicodin, totalling about 300
tablets, approximately once every two (2) weeks to Patient #3.

92. Respondent’s medical records for Patient #3 fail to
reflect any attempts to treat Patient #3’5 pain with alternate
modalities, and fail to reflect any appropriate consultations for
Patient #3'5 pain.

COUNT SEVEN

 

93. Petitioner reallges and incorporates one (1), two (2),
sixty-one (61), sixty—three (63), and eighty—one (81) through
ninety-two (92), as if fully set forth herein this Count Seven.

94. Respondent prescribed, dispensed, administered, mixed,
or otherwise prepared a legend drug, including any controlled
substance, other than in the course of his professional practice,
in that Respondent inappropriately prescribed Vicodin to Patient
#3 for an extended period of time, continued to prescribe Vicodin
to Patient #3 after discussing Patient #3’5 potential addiction
problem with Patient #3, and prescribed Vicodin on at least one
occasion without recording the prescriptions in Patient #3's
medical records.

95. Based on the foregoing, Respondent violated Section
458.331(1)(q), Florida Statutes, by prescribing, dispensing,
administering, mixing, or otherwise preparing a legend drug,
including any controlled substance, other than in the course of the
physician's professional practice.

COUNT EIGHT

15

CD
CD
C3
C3
LO

96. Petitioner realleges and incorporates paragraphs one (1),
two (2), sixty-one (61), sixty-three (63), eighty-one (81) through
ninety-two (92), and ninety-four (94), as if fully set forth herein
this Count Eight.

97. Respondent failed to practice medicine with that level
of care, skill, and treatment which is recognized by a reasonably
prudent similar as being acceptable under similar conditions and
circumstances, in that Respondent inappropriately treated Patient
#3 by prescribing Vicodin for an extended period of time, failed
to attempt alternate treatment modalities to manage Patient #3’5
pain, and failed to attain appropriate consultations for Patient
#3’5 pain management.

98. Based on the foregoing, Respondent violated Section
458.331(1)(t), Florida Statutes, by gross or repeated malpractice
or the failure to practice medicine with that level of care, skill,
and treatment which is recognized by a reasonably prudent similar
physician as being acceptable under similar conditions and
circumstances.

COUNT NINE

99. Petitioner realleges and incorporates paragraphs one (1),
two (2), sixty—one (61), sixty-three (63), eighty-one (81) through
ninety-two (92), ninety—four (94), and ninety-seven (97), as if

fully set forth herein this Count Nine.

justifying the course of treatment of Patient #3, in that

Respondent’s records fail to justify the excessive prescribing of

16

080832

Vicodin over an extended period of time to Patient #3, fail to
justify the continued prescribing of Vicodin to Patient #3 after
discussing Patient #3’5 potential addiction problem with Patient
#3, and fail to record on at least one occasion a prescription for
Vicodin to Patient #3.

101. Based on the foregoing, Respondent violated Section
458.331(1)(m), Florida Statutes, by failing to keep written medical
records justifying the course of treatment of the patient,
including, but not limited to, patient histories; examination
results; test results; records of drugs prescribed, dispensed, or
administered; and reports of consultations and hospitalizatiéns.

WHEREFORE, the Petitioner respectfully requests the Board of
Medicine enter an Order imposing one or more of the following
penalties: revocation or suspension of the Respondent’s license,
restriction of the Respondent’s practice, imposition of an
administrative fine, issuance of a reprimand, placement of the

Respondent on probation, and/or any other relief that the Board

deems appropriate. // /\
’3
SIGNED this C33 day of Lgiﬁéé? , 1991.
Geo sﬁé

     

. McPherson, Jr.

Chief Medical Attorney
COUNSEL FOR DEPARTMENT:

Larry G. McPherson, Jr. k
Chief Medical Attorney F I L E D
Florlda Bar #733543 . . DepartmemofPlofessnonal Reguiatloﬁ
Department of Profess;ona1 Regulatlon AGENUYCLERK
1940 North Monroe Street
Tallahassee, Florida 32399~0750 ( 412

17 ' M

CLERK

 

DATE

 

LAQP/BG/tb
PCP: July 12, 1991
Burt and Campbell

18

CD

L7.)

433“

FIELED

STATE OF FLORIDA AGE‘MQY FOR
AGENCY FOR HEALTH CARE ADMINISTRATIOIWEALTH CARE.DM!NISTHA110A
BEFORE THE BOARD OF MEDICINE DENT" M36 9 ~
01.23 L, 7.4444,! / ‘ 74
AGENCY FOR HEALTH CARE DA , \ ,_
ADMINISTRATION, E&k
PETITIONER
AHCA CASE N0.: 90-03964, 91-09060
v. LICENSE NO.: ME 0048344

Freedland L. Williams, II, M.D.,
RESPON DEN T

ORDER OF TERMINATION

Upon review of the terms and conditions of the Final Order of the Board of Medicine rendered
12/29/93, the documentation offered on behalf of Respondent, and being otherwise fully advised
in the premises, it is hereby

ORDERED AND ADJUDGED:

that Respondent completed his/her period of probation on 12/28/96 and has complied with all
terms of the Final Order rendered 12/29/93.

DONE AND ORDERED

this 30 day of Mww
h”) . me M pm . A .
M. Kathryn Gm

ett, M .D, Chairperson
Board of Medicine

 

CERTIFICATE OF SERVICE
I HEREBY CERTIFY that a true and correct copy of the foregoing Order has been
provided by certiﬁed mail to Freedland L. Williams, H, MD. at 1195 36th Court, Vero Beach,
FL 32960 and to Steven R. Ballinger, Esquire at 412 SE 18th Street, Ft. Lauderdale, FL 33316

or before 5:00 pm. on this 3 [ day of g 29 g ,1996.

z; / ~
Marm Harris, Executive Director
Board of Medicine

on the Consent Agreement. The Respondent waives conﬁdentiality in this case and authorizes the
Board to review the case materials, including all records included in the case, in conjunction with the
consideration of this Consent Agreement.

4. Respondent neither admits nor denies the allegations of fact contained in the Administrative

Complaint or the Investigative Reports.

SIIPULgTED QQNQLIJSIQES QF LAW

1. Respondent admits that, in his capacity as a licensed physician, he is subject to the
provisions of Chapters 455 and 458, Florida Statutes, and the jurisdiction of the Department and the
Board.

2. Respondent admits that the facts set forth in the Administrative Complaint, if proven, would

constitute violations of Chapter 458, Florida Statutes, as alleged in the Administrative Complaint.

STIPULATED DISPQSITIQN
1. F511 [JRE SQQNQUQL Respondent shall not in the future violate Chapters 455, 458 and

893, Florida Statutes, or the rules promulgated pursuant thereto. Prior to signing this agreement, the
Respondent read Chapters 455, 458, and 893, Florida Statutes, and the rules of the Board of Medicine

in Section 61F6, Florida Administrative Code.

2. BLUE, The Board shall impose an administrative ﬁne in the amount of $5000.00 against
the Respondent. The ﬁne shall be paid by the Respondent to the Board of Medicine within eighteen
(18) months of its imposition by Final Order of the Board.

3. EBQBA 1:195. Respondent’s license to practice medicine shall be placed on probation for
a period of three (3) years.

A. QQEDIHQES DURINQ ERQBATIQH, During the period of probation,

Respondent‘s license shall be limited as follows:

i. INDIREQT §UPERVI§IQN, Respondent shall practice only under the
indirect supervision of a Board-approved physician, hereinafter referred to as the "monitor. ' In this
regard, Respondent shall allow the monitor access to Respondent’s medical records, calendar, patient

logs or other documents necessary for the monitor to supervise Respondent as detailed below.

~ B. gQBLIQATIQES/REQLJIREMENTS QF ERQBAIIQN, During the period of

probation, Respondent shall comply with the following obligations and requirements:

i. Respondent shall appear before the Probation Committee of the Board of
Medicine at the ﬁrst Committee meeting after probation commences, at the last meeting of the
Committee preceding scheduled termination of the probation, and at such other times as requested by
the Committee. Respondent shall be noticed by the Board staff of the date, time and place of the
Committee meeting whereat Respondent's appearance is required. Failure of Respondent to appear
as requested or directed shall be considered a violation of the terms of this Agreement, and shall
subject the Respondent to disciplinary action.

ii. Respondent shall complete, or show proof of recent completion of, the

course, "Protecting Your Medical Practice, Clinical, Legal and Ethical Issues in Prescribing Abusable

000086

;>

Board—approved equivalent, during the ﬁrst year of probation.
iii. Respondent shall attend twenty-ﬁve (25) hours of Category I Continuing
Medical Education courses in the areas of risk management (5 hours), pain management (10 hours)
and addiction medicine ( 10 hours). Respondent shall submit a written plan to the Chairman of the
Probation Committee for course approval prior to the completion of said courses. In addition,
Respondent shall submit documentation of completion of these courses in his required reports. These
hours shall be in addition to those hours required for renewal of licensure. Unless otherwise approved
by the Board or the Chairman of the Probation Committee, said courses shall consist of a formal live
lecture format.
iv. Respondent may prescribe Schedule II-V controlled substances only in
compliance with the restrictions set forth below:
a. Respondent shall utilize sequentially numbered triplicate prescriptions.
b. Respondent shall immediately provide one copy of each prescription
to the monitor/supervisor.
c. Respondent shall provide one copy of each prescription to the
Depaxtment's investigator within one months after issuing said prescription.
v. Respondent shall be responsible for ensuring that the monitor submits all

required reports.

000387

C. B I YII.

The Monitor shall:

i. Review one hundred (100) percent of Respondent's active patient records
which involve the prescribing of controlled substances at least once a month, for the purpose of
ascertaining the appropriateness and adequacy of diagnosis and treatment and the appropriateness and
proper documentation of all prescriptions. The monitor shall go to Respondent’s ofﬁce once every
month and shall review Respondent's calendar or patient log and compare the records for review with
the copies of the triplicate prescriptions provided by Respondent pursuant to this agreement.

ii. Review all controlled substance prescriptions for proper documentation,
compliance with the order of the Board, and appropriateness of use in relation to the complaints of
the patient and the diagnosis of the Respondent.

iii. Consult with Respondent on all cases involving possible addiction to or
abuse of prescription drugs. For the purposes of this Stipulation, the scope of consultation shall be
as follows:

Respondent and the monitor shall jointly review the records of the patient suspected of
abuse/addiction in order to conﬁrm the initial diagnosis; shall plan what laboratory and other
diagnostic tests should be utilized to conﬁrm the diagnosis; and shall develop a treatment plan to
include appropriate consultations and referrals to suggested treatment or rehabilitation facilities or
programs.

iv. Submit reports on a quarterly basis, in afﬁdavit form, which shall include:

a) A brief statement of why Respondent is on probation.

b) A description of Respondent‘s practice (type and composition).

000008

c) A statement addressing Respondent’s compliance with the terms of
probation.

d) A brief description of the monitor's relationship with the Respondent.

e) A statement advising the Board of any problems which have arisen.

t) A summary of the dates the monitor went to Respondent‘s ofﬁce, the
number of records reviewed, and the overall quality of the records reviewed.

v. Maintain contact with the Respondent on a frequency of at least once every
two weeks. In the event that the monitor is not timely contacted by Respondent, then the monitor shall
immediately report this fact in writing to the Board.

vi. Respondent‘s monitor shall appear before the Probation Committee at the
ﬁrst meeting of said committee following commencement of the probation, and at such other times as
directed by the Committee. It shall be Respondent’s responsibility to ensure the appearance of his
monitor to appear as requested or directed. If the approved monitor fails to appear as requested or
directed by the Probation Committee, the Respondent shall immediately cease practicing medicine until

such time as the approved monitor or alternate monitor appears before the Probation Committee.

D. EEPQB I S EBQM REPQN DEE L The Respondent shall submit quarterly reports,

in afﬁdavit form, the contents of which may be further speciﬁed by the Board, but which shall

include:

i. A brief statement of why Respondent is on probation.

ii. A description of practice location.

iii. A description of current practice (type and composition).

000009

.A,

iv. A brief statement of compliance with probationary terms.

v. A description of the relationship with monitoring physician.

vi. A statement advising the Board of any problems which have arisen.

vii. A statement addressing compliance with any restrictions or requirements
imposed.

E. STANDARD PRQVISIQNS. Respondent’s probation shall be governed by the
attached "provisions regarding monitoring/supervising physicians,” Exhibit B, which is incoxporated
as if fully set forth herein.

4. PRN QQNTRAQQI. Respondent shall remain under contract with the Physician’s Recovery
Network (PRN) throughout the period covered by this agreement. Respondent shall further remain
in compliance with the terms of the PRN contract and the requirements of the program during this
time period.

5. It is expressly understood that this Agreement is subject to the approval of the Board and
the Department. In this regard, the foregoing paragraphs (and only the foregoing paragraphs) shall
have no force and effect unless a Final Order incorporating the terms of this Agreement is entered by
the Board.

6. Respondent shall appear before the Board at the meeting of the Board where this Agreement
is considered. Respondent, in conjunction with the consideration of this Agreement by the Board,
shall respond to questions under oath from the Board, Board Staff or Department Staff.

7. Should this Agreement be rejected, no statement made in furtherance of this Agreement by
the Respondent may be used as direct evidence against the Respondent in any proceeding; however,

such statements may be used by the Petitioner for impeachment purposes

0000!

CB

